Orthobiological Therapies in Musculoskeletal Disorders
Clinical and Functional Evaluation of Orthobiological Therapies in Musculoskeletal Conditions
PROREGEN
300 participants
Sep 16, 2026
INTERVENTIONAL
Conditions
Summary
To evaluate the clinical and functional effects of using orthobiological therapies (hyaluronic acid, platelet-rich plasma, bone marrow aspirate, nanofat, among others) in the treatment of various musculoskeletal diseases in patients routinely treated at the Proregen Medical Clinic and its affiliates. The sample will consist of adult patients (≥18 years), of both sexes, with different musculoskeletal diagnoses involving joints, tendons, ligaments, cartilage or bone, among others.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Obtained by centrifuging blood, it concentrates platelets and growth factors for regeneration.
Bone marrow aspirate, rich in mesenchymal stem cells and progenitor cells for tissue repair.
Used for joint lubrication and cartilage protection, very common in osteoarthritis.
It is an even more refined and liquefied form of processed fat, used primarily for high-precision tissue repair.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07434115